At a glance
- Originator Wyeth
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anaerobic infections
Most Recent Events
- 03 Aug 1998 No-Development-Reported for Anaerobic infections in USA (Unknown route)
- 08 May 1995 New profile
- 08 May 1995 Preclinical development for Anaerobic infections in USA (Unknown route)